IGF-LR3
$41.99
IGF-1 LR3 is a modified analog of insulin-like growth factor 1 studied for its interaction with IGF receptors and cellular growth signaling pathways [1,2].
This peptide is for research purposes only. Not for human consumption.
In stock
Description
Receptor Binding and Signaling
The LR3 modification alters receptor affinity and binding kinetics, allowing detailed signaling analysis [1].
Cell Growth Pathway Research
Studies explore IGF-LR3 in relation to proliferation, differentiation, and metabolic signaling models [2].
Comparative Growth Factor Studies
IGF-LR3 is often compared with native IGF-1 to examine structural and signaling differences [1].
Key Specs
- Peptide class: IGF-1 analog
- Research context: growth factor signaling
- References: PubChem, PubMed [1,2]
Referenced Citations
- PubChem, IGF-1 LR3: https://pubchem.ncbi.nlm.nih.gov/compound/IGF-1-LR3
- PubMed, IGF-1 receptor signaling: https://pubmed.ncbi.nlm.nih.gov/7521358/
Receptor Binding and Signaling
The LR3 modification alters receptor affinity and binding kinetics, allowing detailed signaling analysis [1].
Cell Growth Pathway Research
Studies explore IGF-LR3 in relation to proliferation, differentiation, and metabolic signaling models [2].
Comparative Growth Factor Studies
IGF-LR3 is often compared with native IGF-1 to examine structural and signaling differences [1].
Key Specs
- Peptide class: IGF-1 analog
- Research context: growth factor signaling
- References: PubChem, PubMed [1,2]
Referenced Citations
- PubChem, IGF-1 LR3: https://pubchem.ncbi.nlm.nih.gov/compound/IGF-1-LR3
- PubMed, IGF-1 receptor signaling: https://pubmed.ncbi.nlm.nih.gov/7521358/
